Cancer vaccine prevents deadly melanoma from returning or spreading in landmark trial
Top Story
Archived
•
August 20, 2026
•
Merck and Moderna's mRNA cancer vaccine hit its Phase 3 trial endpoint, showing improved recurrence-free survival in melanoma patients after surgery.
Source: FoxNews | https://feeds.feedburner.com/foxnews/latest - Read Original
"Camping the Easyway"
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!
Sponsored
